FindTrial
Sign In

Efficacy of Topical Ketorolac Versus Placebo for Improving Visual Outcomes Following Multifocal IOL Implantation

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00433225
Enrollment
Unknown
Registered
2007-02-09
Start date
Unknown
Completion date
Unknown
Last updated
2007-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Macula Thickening

Brief summary

The purpose of this study was to evaluate the efficacy of ketorolac 0.4% on quality of vision and macula thickening in patients undergoing cataract surgery using the ReStor® multifocal IOL.

Interventions

DRUGPrednisolone Acetate
DRUGKetorolac 0.4%
DRUGGatifloxacin 0.3%

Sponsors

Innovative Medical
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
SINGLE

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum

Inclusion criteria

* Males or females \> 50 years old * Scheduled to undergo bilateral phacoemulsification with implantation of a multifocal IOL. * Likely to complete all study visits and able to provide informed consent * Visual potential of 20/25 or better

Exclusion criteria

* · Prior use of topical ketorolac * Known contraindications to any study medication or ingredients * Active ocular diseases or uncontrolled systemic disease * Active ocular allergies

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026